73
Views
0
CrossRef citations to date
0
Altmetric
Letters

SARS-CoV-2 test patterns in Danish patients with inflammatory rheumatic diseases during the COVID-19 pandemic

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 321-323 | Accepted 29 Nov 2022, Published online: 12 Jan 2023

References

  • Busk PK, Kristiansen TB, Engsig-Karup A. Assessment of the national test strategy on the development of the COVID-19 pandemic in Denmark. Epidemiologia 2021;2:540–52.
  • Cordtz R, Lindhardsen J, Soussi BG, Vela J, Uhrenholt L, Westermann R, et al. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark. Rheumatology (Oxford) 2021;60:SI59–67.
  • Cordtz R, Kristensen S, Dalgaard LPH, Westermann R, Duch K, Lindhardsen J, et al. Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark. J Clin Med 2021;10:3842.
  • Hasseli R, Mueller-Ladner U, Schmeiser T, Hoyer BF, Krause A, Lorenz HM, et al. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open 2020;6:1–9.
  • England BR, Roul P, Yang Y, Kalil AC, Michaud K, Thiele GM, et al. Risk of COVID-19 in rheumatoid arthritis: a national Veterans Affairs matched cohort study in at-risk individuals. Arthritis Rheumatol 2021;73:2179–88.
  • Glintborg B, Jensen DV, Engel S, Terslev L, Pfeiffer Jensen M, Hendricks O, et al. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open 2021;7:1–13.
  • Sjölander A, Greenland S. Ignoring the matching variables in cohort studies – when is it valid and why? Stat Med 2013;32:4696–708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.